C8-Ceramide

CAS : 74713-59-0

Ref. 3D-FC19618

Informations sur le produit

• Nom: C8-Ceramide
• Synonymes: N-OctanoylsphingosineN-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]octanamide[R-[R*,S*-(E)]]-N-[2-Hydroxy-1-(hydroxymet hyl)-3-heptadecenyl]octanamide, Octanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-, Octanamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E)]]-, Octanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]octanamide, N-Octanoylsphingosine

Description

C8-Ceramide is a glucosylceramide that is involved in the production of C8-ceramides. It has shown to have potent apoptosis activity and inhibit p21, an inhibitor of cell cycle progression. C8-Ceramide also has been shown to be an inhibitor of tumor necrosis factor alpha (TNF-α) induced inflammation and apoptosis in mouse tumor cells. In addition, it can induce apoptosis by inhibiting the epidermal growth factor receptor (EGFR) pathway. This polymerase chain reaction (PCR) product was found to bind to DNA in a model system using calf thymus DNA as well as bacterial DNA gyrase and topoisomerase IV enzymes.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 425.69 g/mol
• Formule: C₂₆H₅₁NO₃
• Degré de pureté: Min. 95%